Navigation Links
Study of 137 Meniscus Transplant Procedures in Patients with Arthritis is Presented to the Meniscus Transplantation Study Group at the American Academy of Orthopaedic Surgeons Annual Meeting
Date:3/6/2008

Follow-Up Study Supports Biologic Joint Reconstruction Rather Than

Artificial Total Knee Replacement

SAN FRANCISCO, March 6 /PRNewswire/ -- In a report to the meeting of the Meniscus Transplantation Study Group, presented during the 2008 meeting of the American Academy of Orthopaedic Surgeons, Kevin R. Stone, M.D., of the Stone Research Foundation, San Francisco, presented an update on the outcome of 137 patients with arthritis who have undergone allograft replacement procedures of the meniscus since 1997.

In the follow-up study of objective clinical evaluation and imaging of the knee and the patients' subjective evaluation, 111 patients experienced successful outcomes after periods ranging from three months to 10.5 years. The failure rate was 19% with a mean time to failure of 4.79 years.

The allograft replacement procedure replaces the meniscus with a donor allograft. The procedure, which is used to protect the articular cartilage and/or reduce pain, is performed on an outpatient basis and is done arthroscopically and is, therefore, minimally invasive.

"The importance of this study," according to Dr. Stone, "is that it documents that meniscus replacement is an excellent option for some patients facing artificial total knee replacement. It can reduce patient pain and also delay the necessity for total replacement."

"The study also showed," he said, "that meniscal allograft transplantation is a viable treatment option for arthritic patients of all ages."

Among the unexpected study results was the variation in the objective and subjective evaluations of the procedure's success. In some cases, patients reported reduced or no pain when the objective evaluation and imaging seemed to indicate significant arthritis.

"Thus, subjective patient outcomes are critical in evaluating the success of the procedure," said Dr. Stone.

About The Stone Research Foundation

The Stone Research Foundation engages in research, development and education to prevent, treat and reverse arthritis and joint injuries. Its goal is to find minimally invasive biologic joint replacement treatments. It seeks to harness natural healing and regenerative capacities to reconstruct joints damaged by arthritis and injury. The Stone Research Foundation is a non-profit 501( c )3 organization (Tax I.D. # 94-3228007).

For more information, please contact:

Stephanie Stern, Stern & Co. at 212 888-0044


'/>"/>
SOURCE Stone Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New study sheds light on excessive drinking among the elderly
2. When it comes to emotions, Eastern and Western cultures see things very differently: Study
3. Aromatherapy Falls Short, Study Finds
4. New Study: Aging Baby Boomers Could Overwhelm U.S. Health Care System by 2017, Unless Decisive Action Is Taken
5. Carnegie Mellon study shows just listening to cell phones significantly impairs drivers
6. Southgate Community Schools To Present Studywiz Spark at Michigan Computer Users in Learning (MACUL) Conference
7. WHI follow-up study: Risks of long-term hormone therapy continue to outweigh benefits
8. Diamonds Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers Health and Wealth Needs
9. Study shows cholesterol-lowering power of dietitian visits
10. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
11. Genome-wide association study on Parkinsons disease finds public home at NIH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... In an effort to provide hair ... available to both Snapchat users and those who do not use the app. Dr. Mohebi, ... his new page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive ...
(Date:5/26/2016)... ... 2016 , ... Eating Recovery Center, Washington (ERC ... brand new child and adolescent residential treatment center on June 1. The 18-bed, ... specialized eating disorder treatment and access to life-saving care. , To celebrate, ERC ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... offering campers a multitude of activities from daily practices, arts & crafts, discussions, ... Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Eugene Batelli, ... Along with his wonderful accolades and stellar patient reviews, Dr. Batelli continues to ... , Dr. Eugene Batelli is a highly trained Podiatric Surgeon who specializes in ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
(Date:5/25/2016)... -- According to market research "Global Insulin ... Forecast to 2022 - Industry Insights by Type (Insulin ... P&S Market Research, the global insulin delivery device market ... is expected to grow at a CAGR of 6.6% ... is expected to witness the fastest growth at a ...
(Date:5/25/2016)... Digital Health Dialog, LLC dba EngagedMedia ... US Patent and Trademark Office of U.S. Patent ... for electronic opt-­in and processing of discount coupons ... compliance and otherwise. Logo - http://photos.prnewswire.com/prnh/20160524/371583LOGO ... "Our technology allows for individuals to opt­-in to ...
Breaking Medicine Technology: